Cutaneous manifestations of gastrointestinal disease: part II

B Thrash, M Patel, KR Shah, CR Boland… - Journal of the American …, 2013 - Elsevier
The gastrointestinal (GI) and cutaneous organ systems are closely linked. In part I of this
continuing medical education article, the intricacies of this relationship were explored as …

International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia

ME Faughnan, VA Palda, G Garcia-Tsao… - Journal of medical …, 2011 - jmg.bmj.com
Background HHT is an autosomal dominant disease with an estimated prevalence of at least
1/5000 which can frequently be complicated by the presence of clinically significant …

Hormonal and antihormonal therapy for epistaxis in hereditary hemorrhagic telangiectasia

JJ Jameson, DR Cave - The Laryngoscope, 2004 - Wiley Online Library
Abstract Objectives/Hypothesis Objectives were to assess available information on
hormonal therapy for bleeding in hereditary hemorrhagic telangiectasia (HHT), to determine …

Applicability of the Curaçao criteria for the diagnosis of hereditary hemorrhagic telangiectasia in the pediatric population

KS Pahl, A Choudhury, K Wusik, A Hammill… - The Journal of …, 2018 - Elsevier
Objective To evaluate the accuracy of the clinical Curaçao criteria in the diagnosis of
hereditary hemorrhagic telangiectasia (HHT) in children and adolescents. Study design This …

The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis

RJ Harvey, J Kanagalingam… - American journal of …, 2008 - journals.sagepub.com
Background A variety of modalities are available for the control of recurrent epistaxis in
hereditary hemorrhagic telangiectasia (HHT). Laser ablation, in particular potassium-titanyl …

Antiestrogen therapy for hereditary hemorrhagic telangiectasia: a double‐blind placebo‐controlled clinical trial

E Yaniv, M Preis, T Hadar, J Shvero… - The …, 2009 - Wiley Online Library
Abstract Objectives/Hypothesis: Hereditary hemorrhagic telangiectasia (HHT) is associated
with recurrent epistaxis in 90% of cases. Good response to hormone treatment has been …

Laser‐assisted control of epistaxis in hereditary hemorrhagic telangiectasia: A systematic review

A Abiri, K Goshtasbi, M Maducdoc… - Lasers in surgery …, 2020 - Wiley Online Library
Background and Objectives Hereditary hemorrhagic telangiectasia (HHT), also known as
Osler–Weber–Rendu disease, causes recurrent mucous membrane hemorrhage, especially …

[HTML][HTML] Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations: clinical aspects

NM Meier, ML Foster, JT Battaile - Cardiovascular Diagnosis and …, 2018 - ncbi.nlm.nih.gov
Hereditary hemorrhagic telangiectasia (HHT) is a genetic disorder of blood vessel formation
resulting in mucocutaneous telangiectasias and visceral arteriovenous malformations …

Pulmonary arteriovenous malformations in children with hereditary hemorrhagic telangiectasia: a longitudinal study

KL Mowers, L Sekarski, AJ White… - Pulmonary …, 2018 - journals.sagepub.com
Pulmonary arteriovenous malformations (PAVMs) often occur in children with hereditary
hemorrhagic telangiectasia (HHT). A 14-year longitudinal study of PAVMs in children with …

Systematic screening in hereditary hemorrhagic telangiectasia: a review

S Kroon, RJ Snijder, ME Faughnan… - Current Opinion in …, 2018 - journals.lww.com
Systematic screening in hereditary hemorrhagic telangiectasi... : Current Opinion in Pulmonary
Medicine Systematic screening in hereditary hemorrhagic telangiectasia: a review : Current …